Risk factors and prevention of late-onset sepsis in premature infants

Early Human Development

Volumn 86, Issue SUPPL. 1, 2010, Pages 7-12

  Downey, L Corbin ^a   Smith, P Brian ^b   Benjamin, Daniel K ^b  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTASTAPH; FLUCONAZOLE; IMMUNOGLOBULIN; LACTOFERRIN; NYSTATIN; PAGIBAXIMAB; PLACEBO; UNCLASSIFIED DRUG;

ARTICLE; BLOODSTREAM INFECTION; BREAST MILK; CANDIDIASIS; CENTRAL VENOUS CATHETER; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG DOSE COMPARISON; ENTERIC FEEDING; EXTREMELY LOW BIRTH WEIGHT; GESTATIONAL AGE; HAND WASHING; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; HYGIENE; INFANT; INFANT FEEDING; INFANT MORTALITY; INFECTION RATE; INFECTION RISK; LACTOBACILLUS RHAMNOSUS; LATE ONSET SEPSIS; LOW BIRTH WEIGHT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; NEWBORN SEPSIS; PREMATURITY; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; STAPHYLOCOCCUS INFECTION; VERY LOW BIRTH WEIGHT; COMORBIDITY; MICROBIOLOGY; NEWBORN; ONSET AGE; PHYSIOLOGY; REVIEW; SEPSIS;

AGE OF ONSET; COMORBIDITY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; RISK FACTORS; SEPSIS;

EID: 77949274017     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2010.01.012     Document Type: Article

References (47)

1. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110:285-291.
2. Jiang J., Chiu N., Huang F., Kao H., Hsu C., Hung H., et al. Neonatal sepsis in the neonatal intensive care unit: characteristics of early versus late onset. J Microbiol Immunol Infect 2004, 37:301-306.
3. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002, 347:240-247.
4. Karlowicz M.G., Buescher E.S., Surka A.E. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000, 106:1387-1390.
5. Perlman S.E., Saiman L., Larson E.L. Risk factors for late-onset healthcare-associated bloodstream infections in patients in neonatal intensive care units. Am J Infect Control 2007, 35:177-182.
6. Benjamin DK, DeLong E, Cotten CM, Garges HP, Steinbach WJ, Clark RH. Mortality following blood culture in premature infants: Increased with gram-negative bacteremia and candidemia, but not gram-positive bacteremia. J Perinatol 2004;24:175-80.
7. Ronnestad A, Abrahamsen TG, Medbo S, Reigstad H, Lossius K, Kaaresen PI, et al. Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics 2005;115:e269-76.
8. Tseng Y, Chiu Y, Wang J, Lin H, Lin H, Su B, Chiu H. Nosocomial bloodstream infecrion in a neonatal intensive care unit of a medical center: a three-year review. J Microbiol immunol Infect 2002;35:168-72.
9. Feja K.N., Wu F., Roberts K., Loughrey M., Nesin M., Larson E., et al. Risk factors for candidemia in critically ill infants: a matched case-control study. J Pediatr 2005, 147:156-161.
10. Stoll B.J., Hansen N.I., Adams-Chapman I., Fanaroff A.A., Hintz S.R., Vohr B., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004, 292:2357-2365.
11. Benjamin D.K., Stoll B.J., Fanaroff A.A., McDonald S.A., Oh W., Higgins R.D., et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18-22months. Pediatrics 2006, 117:84-92.
12. Smith P.B., Morgan J., Benjamin D.K., Fridkin S.K., Sanza L.T., Harrison L.H., et al. Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J 2007, 26:197-200.
13. Su B., Hsieh H., Chiu H., Lin H., Lin H. Nosocomial infection in a neonatal intensive care unit: a prospective study in Taiwan. Am J Infect Control 2007, 35:190-195.
14. Smith P.B., Cohen-Wolkowiez M., Benjamin D.K., Cotten C.M., Clark R.H., Benjamin D.K. Late Onset Sepsis in the Neonatal Intensive Care Unit. Society for Pediatric Research, Honolulu, HI 2008.
15. Cotten C.M., McDonald S., Stoll B., Goldberg R.N., Poole K., Benjamin D.K., et al. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006, 118:717-722.
16. Garland J.S., Alex C.P., Sevallius J.M., Murphy D.M., Good M.J., Volberding A.M., et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect Control Hosp Epidemiol 2008, 29:243-249.
17. Smith P.B., Benjamin D.K., Cotten C.M., Schultz E., Guo R., Nowell L., et al. Is an increased dwell time of a peripherally inserted catheter associated with an increased risk of bloodstream infection in infants?. Infect Control Hosp Epidemiol 2008, 29:749-753.
18. Boyce J.M., Pittet D. Guideline for hand hygiene in health-care settings. Recommendations of the healthcare infection control practices advisory committee and the HICPAS/SHEA/APIC/IDSA hand hygiene task force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Disease Society of America. MMWR Recomm Rep 2002, 51(RR-16):1-45. Healthcare Infection Control Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task ForceHICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force.
19. Capretti M.G., Sandri F., Tridapalli E., Galletti S., Petracci E., Faldella G. Impact of a standardized hand hygiene program on the incidence of nosocomial infection in very low birth weight infants. Am J Infect Control 2008, 36:430-435.
20. Lam B.C.C., Lee J., Lau Y.L. Hand hygiene practices in a neonatal intensive care unit: a multimodal intervention and impact on nosocomial infection. Pediatrics 2004, 114:e565-e571.
21. Pessoa-Silva C.L., Hugonnet S., Pfister R., Touveneau S., Dharan S., Posfay-Barbe K., et al. Reduction of health care-associated infection risk in neonates by successful hand hygiene promotion. Pediatrics 2007, 120:e382-e390.
22. Relationship between probable nosocomial bacteraemia and organizational and structural factors in UK neonatal intensive care units. Qual Saf Health Care 2005, 14:264-269. UK Neonatal Staffing Study Group.
23. Whitby M., McLaws M., Slater K., Tong E., Johnson B. Three successful interventions in health care workers that improve compliance with hand hygiene: is sustained replication possible. Am J Infect Control 2008, 36:349-355.
24. Larson E.L., Cimiotti J., Haas J., Parides M., Nesin M., Della-Latta P., et al. Effect of antiseptic handwashing vs alcohol sanitizer on health care-associated infections in neonatal intensive care units. Arch Pediatr Adolesc Med 2005, 159:377-383.
25. Ng P.C., Wong H.L., Lyon D.J., So K.W., Liu F., Lam R.K.Y., et al. Combined use of alcohol hand rub and gloves reduces the incidence of late onset infection in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2004, 89:F336-F340.
26. Ballow M., Cates K.L., Rowe J.C., Goetz C., Desbonnet C. Development of the immune system in very low birth weight (less than 1500g) premature infants: concentrations of plasma imunoglobulins and patterns of infections. Pediatr Res 1986, 20:899-904.
27. Baker C.J., Melish M.E., Hall R.T., Castro D.T., Vasan U., Givner L.B. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates. N Engl J Med 1992, 327:213-219.
28. Fanaroff A.A., Korones S.B., Wright L.L., Wright E.C., Poland R.L., Bauer C.B., et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. N Engl J Med 1994, 330:1107-1113.
29. Bloom B., Schelonka R., Kueser T., Walker W., Jung E., Kaufman D., et al. Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants. Pediatr Infect Dis J 2005, 24:858-866.
30. DeJonge M., Burchfield D., Bloom B., Duenas M., Walker W., Polak M., et al. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr 2007, 151:260-265.
31. Benjamin D.K., Schelonka R., White R., Holley H.P., Bifano E., Cummings J., et al. A blinded, randomized, multicenter study of an intravenous Staphyloccus aureus immune globulin. J Perinatol 2006, 26:290-295.
32. Thackray H., Lassiter W., Walsh W., Brozanski B., Steinhorn R., Dhanireddy R., et al. Phase II Randomized, Double Blind, Placebo-Controlled, Safety, Pharmacokinetics (PK), and Clinical Activity Study in Very Low Birth Weight (VLBW) Neonates of Pagibaximab, a Monoclonal Antibody for the Prevention of Staphylococcal Infection. Poster Presentation, Society for Pediatric Research, San Francisco, CA 2006.
33. Flidel-Rimon O., Friedman S., Lev E., Juster-Reicher A., Amitay M., Shinwell E.S. Early enteral feeding and nosocomial sepsis in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2004, 89:F289-F292.
34. Hylander M.A., Strobino D.M., Dhanireddy R. Human milk feedings and infection among very low birth weight infants. Pediatrics 1998, 102:e38-e43.
35. Sisk P.M., Lovelady C.A., Dillard R.G., Gruber K.J., O'Shea T.M. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol 2007, 27:428-433.
36. Manzoni P., Mosca F., Messner H., Magaldi R., Cattani S., Stronati M., et al. A Multicenter Randomized Trial on Prophylactic Bovine Lactoferrin in Preterm Neonates: Preliminary Data 2008, Society for Pediatric Research, Honolulu, HI.
37. Arnold R.R., Brewer M., Gauthier J.J. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun 1980, 28:893-898.
38. Barriga F.J., Varas M., Potin M., Sapunar F., Rojo H., Martinez A., et al. Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Med Pediatr Oncol 1997, 28:196-200.
39. Henrickson K.J., Axtell R.A., Hoover S.M., Kuhn S.M., Pritchett J., Kehl S.C., et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 2000, 18:1269-1278.
40. Garland J.S., Alex C.P., Henrickson K.J., McAuliffe T.L., Maki D.G. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 2005, 116:e198-e205.
41. Ozturk M.A., Gunes T., Koklu E., Cetin N., Koc N. Oral nystatin prophylaxis to prevent invasive candidiasis in neonatal intensive care unit. Mycoses 2006, 49:484-492.
42. Kaufman D., Boyle R., Hazen K.C., Patrie J.T., Robinson M., Donowitz L.G. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001, 345:1660-1666.
43. Kaufman D., Boyle R., Hazen K.C., Patrie J.T., Robinson M., Grossman L.B. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. J Pediatr 2005, 147:172-179.
44. Manzoni P., Stolfi I., Pugni L., Decembrino L., Magnani C., Vetrano G., et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 2007, 356:2483-2495.
45. Saiman L., Ludington E., Pfaller M., Rangel-Frausto S., Wiblin R.T., Dawson J., et al. Risk factors for candidemia in neonatal intensive care unit patients. Pediatr Infect Dis J 2000, 19:319-324.
46. Benjamin D.K. First, do no harm. Pediatrics 2008, 121:831-832.
47. Andersen D.H., Blanc W.A., Crozier D.N., Silverman W.A. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 1956, 18:614-625.